These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2110089)

  • 1. Levamisole inhibits in vivo rat platelet aggregation by a release of prostacyclin-like factor.
    Pinto A; Sorrentino R; Sorrentino L
    Gen Pharmacol; 1990; 21(2):255-9. PubMed ID: 2110089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man.
    Küster LJ; Frölich JC
    Prostaglandins; 1986 Sep; 32(3):415-23. PubMed ID: 3097760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
    Gentry PA; Niemuller C; Ross ML; Liptrap RM
    Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique.
    Martin JF; Suggett AJ; Jones PB; Leach E
    Thromb Res; 1982 Aug; 27(3):251-9. PubMed ID: 6814004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
    Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid.
    Minuz P; Lechi C; Tommasoli R; Gaino S; Degan M; Zuliani V; Bonapace S; Benoni G; Adami A; Cuzzolin L
    Thromb Res; 1995 Dec; 80(5):367-76. PubMed ID: 8588198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat.
    Emms H; Lewis GP
    Br J Pharmacol; 1986 Jan; 87(1):109-15. PubMed ID: 3082399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.
    Reynaud D; Hinek A; Pace-Asciak CR
    FEBS Lett; 2002 Mar; 515(1-3):58-60. PubMed ID: 11943194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP; Camara S; Bellido I; Carrasco T; Sanchez de la Cuesta F
    Thromb Res; 1987 Apr; 46(1):133-40. PubMed ID: 3109069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study.
    de la Cruz JP; Bellido I; Camara S; Martos F; Sanchez de la Cuesta F
    Scand J Haematol; 1986 Apr; 36(4):394-7. PubMed ID: 3086967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exchange of cyclooxygenase dependent metabolites between vessel wall and platelets in arterial thrombosis.
    Bourgain RH; Andries R; Decuyper K; Braquet P
    Thromb Res; 1988 May; 50(3):401-8. PubMed ID: 3134741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.